| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.057 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |